Cargando…
A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system
CRISPR/Cas9 can be used as an experimental tool to inactivate genes in cells. However, a CRISPR-targeted cell population will not show a uniform genotype of the targeted gene. Instead, a mix of genotypes is generated - from wild type to different forms of insertions and deletions. Such mixed genotyp...
Autores principales: | Shen, Yunbing, Jiang, Long, Iyer, Vaishnavi Srinivasan, Raposo, Bruno, Dubnovitsky, Anatoly, Boddul, Sanjaykumar V., Kasza, Zsolt, Wermeling, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531760/ https://www.ncbi.nlm.nih.gov/pubmed/34745454 http://dx.doi.org/10.1016/j.csbj.2021.09.020 |
Ejemplares similares
-
Designing custom CRISPR libraries for hypothesis-driven drug target discovery
por: Iyer, Vaishnavi Srinivasan, et al.
Publicado: (2020) -
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
por: Jiang, Long, et al.
Publicado: (2022) -
In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors
por: Boddul, Sanjaykumar V., et al.
Publicado: (2021) -
IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints
por: Panda, Sudeepta Kumar, et al.
Publicado: (2020) -
Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis
por: Sharma, Ravi K., et al.
Publicado: (2021)